person

Adnan M.

Country
Denmark
Department
Dept of otorhinolaryngology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
8
Sites with multiple studies

Has run more than one trial at 8 of 12 partner sites.

Specializations

Cardiovascular disease and thrombosis

Clinical research activity includes prevention and treatment strategies for atrial fibrillation, acute myocardial infarction, ischemic stroke, atherosclerotic cardiovascular disease, and broader major adverse cardiovascular events.

  • Stroke prevention and systemic embolism
  • Anticoagulation and antiplatelet therapy
  • Lipid-lowering and cardiovascular risk reduction

Research also covers covert brain infarction, cardiac arrest, hypotension, and post-event vascular protection in high-risk patients.

Rhinosinusitis and upper airway inflammation

Investigational work in otorhinolaryngology includes management of chronic rhinosinusitis with nasal polyposis and biologic treatment strategies for persistent nasal inflammation.

  • Biologic therapy for nasal polyps
  • Disease control in chronic sinonasal inflammation
  • Treatment tapering after long-term symptom control

These studies focus on maintaining symptom control and reducing recurrence in chronic inflammatory disease of the sinonasal tract.

Neurology and neuroinflammatory disease

Clinical interests extend to migraine, multiple sclerosis, early-stage Parkinson’s disease, and acute neurological conditions such as acute ischemic stroke.

  • Migraine prevention
  • Multiple sclerosis disease modification
  • Acute stroke intervention

Additional work includes neurological risk reduction in patients with vascular brain injury and recurrent cerebrovascular events.

Kidney disease and diabetes-related complications

Research activity includes chronic kidney disease, end-stage renal disease, and renal complications in type 1 diabetes mellitus, with attention to albuminuria and cardiovascular-renal protection.

  • Diabetic kidney disease
  • Albuminuria reduction
  • Cardiorenal risk

Related work also addresses metabolic risk in obesity, hypertriglyceridemia, and severe lipid disorders linked to vascular disease.

Oncology and infectious respiratory disease

Trial involvement spans large B-cell lymphoma, multiple myeloma, and non-small cell lung cancer, alongside studies in viral lung infections and respiratory syncytial virus prevention.

  • Lymphoma and myeloma
  • Lung cancer
  • Respiratory infection prevention

These areas reflect involvement in both malignancy-focused care and respiratory infection-related prevention in vulnerable patient groups.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.